AzTrials
AzTrials

InfertilityNCT02639715

Morphometrics and Morphokinetics of Thawed Oocytes and Embryos

An observational study of Infertility, run by Sophie Debrock.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this observational study is to describe for the first time a complete set of morphometric and morphokinetic parameters of frozen-thawed human embryos in order to select the embryo with the highest implantation potential. Read more about this study

Who is it for?
Ages 18 to 40 years, women onlyHealthy volunteers can take part
Conditions the study is for
Infertility
How many people
1,272 participants
Where
No sites listed yet
Study dates
Jan 2014to Dec 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Patients with frozen thawed embryos for an ART treatment cycle

Who may be able to join

  • patients with female age < 40 years at Oocyte retrieval

Who cannot join

  • Patients with female age >40 years at Oocyte retrieval
  • cycles with Preimplantation genetic diagnosis
  • donated gametes

About this study

The aim of this observational study is to describe for the first time a complete set of morphometric and morphokinetic parameters of frozen-thawed human embryos in order to select the embryo with the highest implantation potential. These parameters will be correlated with (1) data of the fresh embryos and their subsequent survival, the evolution of the contact surfaces between surviving blastomeres and the resumption of mitosis; (2) patient characteristics and clinical outcome of frozen-thawed embryos and (3) a comparison between embryos cryopreserved with vitrification or the slow method regarding these parameters will be performed.

This project aims to introduce new evaluation criteria of the frozen-thawed embryos to improve success rate of FET cycles. By establishing new precise, reliable and non-invasive measurable parameters, we aim to (1) select which supernumerary embryos are at chance to survive the freezing/thawing procedures, (2) establish cut off parameters for the survival rate of the embryo, (3) assess implantation, pregnancy and live birth rates depending on the developmental characteristics after thawing and after 24h of culture.

Our strategy for improving the outcome of FET cycles is based on the study of morphometric and morphokinetic parameters in frozen-thawed embryos and the correlation with embryological, clinical and cycle parameters. Transferring a well-defined thawed embryo with a high implantation potential may lead towards an increase in the implantation and life birth rate and an increase in the cumulative live birth rate with a reduction of the IVF costs in order to optimize the health-economic situation of reproductive medicine.

Read the detailed description

Cryopreservation of supernumerary embryos is an essential part of Assisted Reproduction Techniques (ART) and is nowadays a standard routine procedure in the IVF laboratory. Its clinical application consists in (1) the possibility of increasing cumulative delivery rates per cycle and (2) the reduction of the number of transferable embryos in both fresh and successive frozen thawed embryo transfer cycles (FET) decreasing the risk of multiple pregnancies.

Two different techniques to cryopreserve embryos are commonly used: slow freezing and vitrification. During slow freezing, the embryo is exposed to subzero temperatures in a controlled rate with the use of low concentration of cryoprotectant. Alternatively, using vitrification the embryo rapidly enters into a glass-like state with the use of high concentrations of cryoprotectant and rapid cooling rates. Several studies comparing cryopreservation of human embryos by vitrification or slow freezing are available and meta-analyses have been published. Although vitrification has been found to have significantly higher survival rates than slow freezing, results on implantation rate, clinical pregnancy rate and live birth rate remain unclear, mostly due to a paucity of well-designed and powered prospective randomized controlled studies assessing live birth rates.

Embryo evaluation to select the embryo(s) with the highest implantation potential is routinely based on embryo developmental and morphological characteristics using light microscopy. The embryo parameters usually correlated to the implantation capacity of an embryo in a fresh cycle are the number of blastomeres, their symmetry and the percentage cytoplasmic fragmentation. For the evaluation of frozen-thawed embryos, the percentage of blastomeres that survive the freezing-thawing process and their developmental capacity after overnight culture have to be added to these factors.

Current research in the development of non-invasive methods for scoring embryos and ranking them according to their ability to implant and give rise to a healthy birth include both morphometrics and morphokinetics.

Morphometrics Multilevel computerized images enable assessment over an unlimited time period and allow a detailed evaluation of the embryo. Several morphometric studies of human fresh oocytes and embryos with embryo implantation and development have been published. Morphometric studies using multilevel images combined with a computer-assisted scoring system (CASS) may be superior compared to standard scoring system (SSS) to predict implantation and/or live birth based on the number and size of blastomeres on day 3. Semi-automated morphometric analysis also revealed correlations between total embryo volume and clinical pregnancy. Another study evaluating morphometric characteristics including the absolute volumes, coefficients of form and the coefficient of diversity of human embryos and/or oocytes showed a higher coefficient of diversity between sister blastomeres in embryos that successfully implanted and progressed to birth. Morphometric characteristics including the external and internal diameter of the zona pellucida, the thickness of the zona pellucida and the embryo cell mass diameter were described. They stated that image analysis could be used to predict the criteria needed for more efficient embryo assessment before transfer. The mean blastomere size was correlated with the degree of fragmentation and multinucleation in a study using computer-controlled multilevel analyses with 232 embryos. However, until now, no morphometric studies in human frozen thawed embryos have been described.

Morphokinetics Time-lapse imaging allows documentation of early growth without disturbing the culture environment. At this moment, no prospective randomized trial data are available showing that embryos selected from time-lapse imaging have significantly improved implantation rates compared with embryos selected with conventional morphological evaluation.

However, time lapse imaging of embryos have revealed a correlation between first cleavage time, time between cleavages, blastomere size and multinucleation and implantation potential of human embryos. A correlation between the times of each embryo cleavage between 2 to 8 cell stage, the ability to become a blastocyst and implantation potential. Moreover, morphokinetic studies have demonstrated that direct cleavage from 2 cells to 3 cells has been correlated with a low implantation and ongoing pregnancy rate. According to time-lapse recording in 38 oocytes, embryo quality was related to fertilization events and periodicity of the cyctoplasmic wave: good quality embryos arose from oocytes that had more uniform timing from injection to pronuclear abuttal and longer cytoplasmic wave. Furthermore, cellular fragments in human embryos can disappear during in vitro culture.

Only a few studies on morphokinetics in human cryopreserved embryos have been published. Using videocinematography on respectively 50 and 103 frozen-thawed embryos, it was shown that the occurrence of smooth membranes and the cell-cell adherence were predictive for the implantation capacity of frozen-cleaved embryos. Wong et al. followed the development of 242 supernumerary frozen d1-old embryos in a study combining time lapse microscopy and gene expression profiling: success in progression to the blastocyst stage could be predicted by measuring three dynamic, noninvasive imaging parameters by day 2 after fertilization before embryonic genome activation: (1) duration of the first cytokinesis, (2) time interval between the end of the first mitosis and the initiation of the second and (3) the time interval between the second and third mitoses.

This observational study aims to describe morphometric and morphokinetic parameters of thawed human embryos after freezing (slow freezing or vitrification). The study will focus on the evolution of the blastomere volume, the evolution of the contact surfaces between surviving blastomeres and the development of the embryo using time lapse imaging. Embryo morphometric and morphokinetic parameters will be analyzed together with patient characteristics and clinical parameters using cluster analysis techniques. The correlation between morphometrics/morphokinetics and the implantation potential of frozen-thawed embryos will be studied in cycles with single embryo transfer and in cycles with dual implantation after double embryo transfer.

Conditions
Infertility
Medical subject headings
Infertility

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. embryo implantation (measured by the number of intrauterine fetal sacs on ultrasound per number of embryos transferred) after a thawing / warming cycle

    Measured: 6-7 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2015 (estimated)
  2. Study startJan 2014
  3. Primary completionDec 2014
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
1,272 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02639715
Sponsor's protocol ID
S55685
Status last verified
Dec 2015
First submitted
15 Dec 2015
Last updated
24 Dec 2015
Results posted
No
Data monitoring committee
No

Publications

  • Fernandez Gallardo E, Spiessens C, D'Hooghe T, Debrock S. Effect of day 3 embryo morphometrics and morphokinetics on survival and implantation after slow freezing-thawing and after vitrification-warming: a retrospective cohort study. Reprod Biol Endocrinol. 2017 Oct 3;15(1):79. doi: 10.1186/s12958-017-0299-5.

    PubMed 28974230
  • Fernandez Gallardo E, Spiessens C, D'Hooghe T, Debrock S. Effect of embryo morphology and morphometrics on implantation of vitrified day 3 embryos after warming: a retrospective cohort study. Reprod Biol Endocrinol. 2016 Jul 30;14(1):40. doi: 10.1186/s12958-016-0175-8.

    PubMed 27475526

Questions about this trial

What is this clinical trial studying?

An observational study of Infertility, run by Sophie Debrock.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

embryo implantation (measured by the number of intrauterine fetal sacs on ultrasound per number of embryos transferred) after a thawing / warming cycle (time frame: 6-7 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02639715, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT02639715 | AzTrials